UnannouncedVCRaise

Filed before 2025Filed 24 January 2020

Athira Pharma, Inc. has sold $3.82M so far

Athira Pharma, Inc., a biotech company based in Seattle, WA, has sold $3.82M so far in its debt round, according to a filing dated 24 January 2020.

Raises filed before 2025 are not checked for a public announcement.

Watch Athira Pharma, Inc. Share on X Read the filing ↗
Filed
24 January 2020
First filed
20 December 2018
Round
Debt round (amended filing)
Amount sold
$3.82M
Offering size
$4.65M
Investors so far
22
Based in
Seattle, WA

Investors on the board

Firms come from the venture funds whose filings name a director of this company.

Who is on the board

1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.

Sign in with Google

How it compares

Larger than 34% of the 1,744 tracked raises with an amount filed in 2020, and than 16% of the 152 in biotech.

Athira Pharma, Inc. in public filings

FiledFilingSoldRaise
12 Jun 2020New filing$89MAnother raise
24 Jan 2020Amended filing$3.82MThis raise
19 Sep 2019Amended filing$2.15MThis raise
23 Jan 2019Amended filing$1.27MThis raise
20 Dec 2018New filing$1.27MThis raise

Everything on Athira Pharma, Inc.

Other unannounced rounds

  1. Thoughtform, Inc.$6.6MUnannounced · 1 day17 Sep 2026 · Palo Alto, CA
  2. ProvenAir Technologies, Inc.$488KUnannounced · 1 day17 Sep 2026 · Chicago, IL
  3. Gravitics, Inc.$17MUnannounced · 1 day17 Sep 2026 · Marysville, WA
  4. SurgiBox Inc.$486KUnannounced · 1 day17 Sep 2026 · Cambridge, MA
  5. Voxel Labs Inc.$10MUnannounced · 1 day17 Sep 2026 · San Francisco, CA
  6. DVx Atomic Co.$18.5MUnannounced · 2 days16 Sep 2026 · Boston, MA

All unannounced rounds

Seen it announced?

Send the link and the check will look at it.